Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Timing of ERCP After ESWL for Chronic Pancreatitis
NCT05270434Completed
- Sponsor
- Changhai Hospital
- Start
- Mar 2025
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Changhai Hospital. Primary endpoint: Successful MPD Cannulation Rates. Started Mar 2025; status: completed.
Beyond the preview
Go deeper on NCT05270434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05270434.